Clinical Trial to Evaluate the Efficacy and Safety of SUBMO® as a Submucosal Injection Agent in Endoscopic Resection of Superficial Gastrointestinal Lesions.

NCT07448129 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Polyps

Interventions

DEVICE: SUBMO® Submucosal Injection
DEVICE: Normal Saline (0.9% Sodium Chloride) with Surface Dye Injection

Sponsor

i+Med S.Coop.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]